Nafamostat is a Potent Human Diamine Oxidase Inhibitor Possibly Augmenting Hypersensitivity Reactions during Nafamostat Administration.
T Boehm, M Alix, K Petroczi, S Vakal… - The Journal of …, 2022 - europepmc.org
Nafamostat is an approved short-acting serine protease inhibitor. However, its
administration is also associated with anaphylactic reactions. One mechanism to augment …
administration is also associated with anaphylactic reactions. One mechanism to augment …
[引用][C] Nafamostat is a Potent Human Diamine Oxidase Inhibitor Possibly Augmenting Hypersensitivity Reactions during Nafamostat Administration
T Boehm, M Alix, K Petroczi, S Vakal… - … of Pharmacology and …, 2022 - cir.nii.ac.jp
Nafamostat is a Potent Human Diamine Oxidase Inhibitor Possibly Augmenting Hypersensitivity
Reactions during Nafamostat Administration | CiNii Research CiNii 国立情報学研究所 学術 …
Reactions during Nafamostat Administration | CiNii Research CiNii 国立情報学研究所 学術 …
Nafamostat is a Potent Human Diamine Oxidase Inhibitor Possibly Augmenting Hypersensitivity Reactions during Nafamostat Administration
T Boehm, M Alix, K Petroczi, S Vakal… - The Journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Nafamostat is an approved short-acting serine protease inhibitor. However, its
administration is also associated with anaphylactic reactions. One mechanism to augment …
administration is also associated with anaphylactic reactions. One mechanism to augment …